.Regeneron is back with lasting follow-up for its own LAG-3 inhibitor and also PD-1 inhibitor combin...
.AstraZeneca has shared an early examine the functionality of its in-house antibody-drug conjugate (...
.After declaring a period 3 launch based on good midstage end results, iTeos and also GSK are ultima...
.The FDA ought to be more open as well as collective to let loose a rise in approvals of uncommon il...
.It's an extraordinarily busy Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bi...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 test, however the bi...
.Neurocrine Biosciences' mental illness program pivot has actually failed. The biotech was incapable...
.Sanofi has actually made a late entry to the radioligand event, paying out one hundred thousand eur...
.After F2G's first try to get a new class of antifungal to market was actually wrecked due to the FD...
.Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The choice to shrink the finances...